INTRODUCTION
It was long held that anterograde transport of proteins along the secretory pathway was nonselective: in the absence of retention or retrieval signals, newly synthesized proteins would move by default from the endoplasmic reticulum (ER) 1 to the Golgi complex en route to lysosomes or the cell surface (1) . Indeed, retention and retrieval signals were identified for many ER and Golgi complex resident proteins (2-6), whereas the search for anterograde signals proved fruitless until very recently. The p24 family of transmembrane proteins and ERGIC-53p, both of which recycle between the ER and the Golgi complex, have a doublephenylalanine signal on their cytosolic region that affects exit from the ER (7, 8) and binds protein components of the coatomer structures (8) . Several other transmembrane proteins have a diacidic motif in the cytosolic domain that determines the rate of ER export (9) (10) (11) (12) .
Moreover, protein movement along the secretory pathway may be metabolically controlled.
Transport of the calcitonin receptor-like receptors Fas and neurotropin to the cell surface is regulated by the level of receptor-activity-modifying proteins p53 and cAMP, respectively (13, 14) , and export of major histocompatibility complex class I proteins from the ER is stimulated by insulin (15) . Consequently, nonselective and signal-mediated anterograde transport probably coexist.
There is some evidence that a carboxyl-terminal valine residue at the cytosolic tail of cell surface transmembrane proteins is an anterograde signal. Deletion or substitution of the 6 immunocomplexes were collected by centrifugation, washed and processed for SDS-PAGE analysis, whereas the supernatant was used to immunoprecipitate intracellular CD8α. To quantify the relative amount of [ 35 S]-methionine-and cysteine-labeled CD8α forms, the dried gels were analyzed with Bio-Rad's Molecular Imager Systems Model 525 using the Bio-Rad Molecular Analyst/Macintosh software.
Cell fractionation. All manipulations were done at 4 °C. About 7-10 x 10 7 cells were homogenized by 10 passages through a cell cracker (8. 
RESULTS

A carboxyl-terminal R/K-Y-V sequence at the cytosolic tail of CD8α protein in higher
mammals. The cytosolic tail of the CD8α is 28 residues long in all mammalian species where it has been sequenced, except in the rat where it has a deletion of 4 consecutive residues ( Fig.   1 ). It has an identity of about 60% in all species examined so far and several conservative changes. The juxtamembrane half of the tail is more conserved than the external half (80% identity versus 35%). This portion of the tail binds p56 lck , the lymphocyte specific tyrosine kinase of the src family (30) (31) (32) , thus the high level of identity may indicate strong evolutionary pressure toward this function. Differently, changes and deletions are present in the external half, where only 5 residues are conserved. Among them, the terminal valine which is preceded at position 27 by tyrosine (except in rodents where isoleucine or phenylalanine is found), and at position 26 by a positively charged residue, either arginine or lysine. Interestingly, chicken CD8α, the only nonmammalian species known, retains close identity with other species in the juxtamembrane half of the tail, but only the lysine and proline residues at position 20-21 in the external portion. However, chicken CD8α presents a terminal isoleucine preceded by histidine and the positively charged arginine. Thus, the terminal portion of the CD8α tail could have progressively evolved to an R/K-Y-V sequence to fulfill a better signaling function. was distributed among the plasma membrane and Golgi complex (Fig. 3) , whereas the tailless CD8α was predominant in the ER and Golgi complex. Interestingly, immunofluorescence microscopy showed that no mutant carried the extreme phenotype of the tail-less protein, all being similar to the wild type. Weak labeling of the nuclear envelope and more pronounced Golgi labeling occurred in mutants ∆V 28 , ∆Y 27 V 28 and V 28 -D (Fig. 3) ; all other mutants were almost undistinguishable from the wild type ( Fig. 3 and data not shown). Western blotting showed a greater effect in some species. As expected, all wild type CD8α was in the CD8m form, whereas CD8u was poorly converted to mature forms in the tail-less CD8α (Fig. 4) . Conversely, the relative amount of both forms decreased in parallel strongly in favor of CD8u in the most affected mutants and less severely in the least affected ones. This parallel behavior 10 of mature and initially glycosylated forms of CD8α suggests that valine-less mutants proceed at normal rate from the cis-Golgi (where CD8i is generated) toward the trans-Golgi region (where CD8m is produced). Consequently, the carboxyl-terminal valine signal is most likely required in the transport step between the ER and the cis-Golgi complex. (34) . Thus, the most relevant mutants were transfected in parallel to the wild type and the newly synthesized proteins analyzed after immunoprecipitation in SDS-PAGE in non-reducing conditions. The mutant and wild-type CD8u forms contained the same relative amounts of dimers after a 15-min pulse (Fig. 6 ). This finding demonstrates that the cytosolic tail does not affect the overall folding of the protein or the ability of the ectodomain to establish interchains disulphide bond(s). Thus, the delayed glycosylation/transport rate can not be ascribed to a prolonged quality control process in the ER.
The addition of a carboxyl-terminal valine accelerates the glycosylation/transport rate of a truncated CD8α form. If a terminal valine residue is needed for a maximal
glycosylation/transport rate of CD8α, addition of a valine to the truncated cytosolic tail of a mutant CD8α protein should improve this rate. To verify this prediction, we extended the carboxyl-terminus of the ∆17 mutant with V or YV (Fig. 2) . The results obtained from the assay described in Fig. 5 are clear: ∆17 had a slower glycosylation/transport rate, and ∆17 plus V or YV had the same rate as the wild type protein (Fig. 7) . Thus, the carboxyl-terminal valine may be sufficient to obtain maximal glycosylation/transport rate. (Fig. 8) . Therefore, neither glycosylation nor transport of CD8α from the trans-Golgi complex to the plasma membrane requires the carboxyl-terminal valine.
Deletion of the carboxyl-terminal valine impairs transport of CD8α from the ER to the intermediate compartment.
Having established that the carboxyl-terminal valine is required for transport of CD8α from the ER to the Golgi complex, we investigated whether the step specifically altered was export from the ER to the IC, or from the IC to the Golgi complex. In the absence of posttranslational modifications specific for the IC, we used cell fractionation after pulse-chase labeling with [
S]-methionine and cysteine. Transport of newly synthesized
CD8α among the ER, IC and Golgi complex can be analyzed by a simple fractionation procedure of stably transfected cells (23, 26) . As shown in Fig. 9 A,B,C, the CD8u form, labeled in a very short pulse, sediments mostly in the ER-enriched region of the discontinuous sucrose gradient, in both the ER and IC-enriched regions after a 5-min chase, and in the ICenriched region after a 2-h chase at 15 °C (a condition that prevents transport to the Golgi complex and leads to accumulation in the IC). Conversely, the newly synthesized CD8u form of mutant ∆V 28 invariably sedimented in the ER-enriched fractions, both after the pulse and after different chase times at 37 °C (Fig. 9 , D,E and data not shown). The same result was obtained after a 2-h chase at 15 °C (Fig. 9F ). As expected, the initially and terminally glycosylated forms of both the wild type and ∆V 28 generated during the chase sedimented in the center of the gradient (data not shown). Taken together, these results together indicate that the absence of the carboxyl-terminal valine impairs specifically the transport step between the ER and IC. The effect of this impairment is a slower and asynchronous exit of CD8α from the ER.
DISCUSSION
We provide evidence that the carboxyl-terminal valine signal in the CD8α protein is important for protein transport to the ER. This anterograde signal is not required for any other step of the exocytic pathway that leads to the plasma membrane.
Earlier studies suggested that the carboxyl-terminal valine is an anterograde signal in the exocytic pathway that increases the rate of ER to Golgi transport. The glycosylation rate of chimeric reporters from yeast Emp24p, a type I transmembrane protein recycling between the ER and the Golgi complex, and of protein Wbp1p was found to be optimal in the Golgi complex only in the presence of the two carboxyl-terminal residues of the cytosolic tail of Emp24, leucine and valine (20) . Data obtained with engineered forms of the human ERGIC53p, another type I transmembrane protein recycling between the ER and the Golgi complex, supports this finding (35) . Similarly, removal of the double-phenylalanine motif decreases the rate of exit from the ER, but the mutated protein retains its capacity to proceed in the exocytic pathway (7, 8) . The carboxyl-terminal valine signal appears to play a more restricted role in the type I transmembrane proteins proTGFα and MT1-MMP, which are normally localized on the cell surface (16, 17) . Results obtained with valine-less constructs showed that both proteins accumulated in the ER. This finding is striking because substantial retention of surface protein in the ER seems to be a feature of remarkably misfolded/unfolded or not oligomerized proteins that fail to pass the quality control process (36), which does not seem to be the case of proTGFα and MT1-MMP (17) . However, studies of the diacidic anterograde motif show that ER export is altered to a different extent upon removal or transfer of the signal to reporter proteins (9, 11, 12) . Thus, the rate of transport from the ER to the Golgi complex seems to be differently altered by the carboxyl-terminal valine, and by the other anterograde signals, depending on the specific cargo protein.
After we had established the role of the carboxyl-terminal valine signal, we addressed the issue of its function at molecular level. It is likely that a signal exposed at the end of the cytosolic tail would determine interaction with cytosolic factors, or factors exposed on the cytosolic side of the ER membrane. These factors may favor concentration of the signalbearing cargo proteins at ER exit sites. In exocrine pancreas, abundant soluble cargo proteins are concentrated equally at the exit sites and over the entire ER, whereas they are three times more concentrated in selected areas of the IC (37) . Conversely, proteins involved in the export or retrieval machinery are more concentrated at the ER exit sites and at different areas of the IC, respectively (37) . These results support a bulk flow mode of ER export for abundant proteins, coupled with selective sorting (and perhaps retrieval) processes in the IC (38) . On the other hand, the VSV G glycoprotein is more concentrated at the ER exit sites and in the IC than in the ER cisternae (39) . The latter findings could be reconciled with the former data assuming that the type of ER export mechanism differs depending on the concentration of the protein cargo, or on whether the cargo consists of soluble or membrane proteins. This may apply to the export-machinery proteins that, unlike cargo, must be continuously retrieved and reused. In a previous study, both immunofluorescence and immunoelectron microscopy showed that wild type does not accumulate in the ER, which is compatible with rapid export of CD8α to the Golgi complex (26) . In the present study, using immunofluorescence microscopy, we found CD8α in the ER when the carboxyl-terminal valine was deleted or substituted. Thus, it would be interesting to investigate the distribution of these mutants in the ER by immunoelectron microscopy. The absence of protein concentration at exit sites would implicate the terminal valine in this step, whereas, protein concentration would point to a different role, for example, in packaging in the transport vesicles.
Vesicles involved in ER export are coated with COPII proteins (40) (41) (42) . Interestingly, the double-phenylalanine motif binds COPII subunits in vitro (8) , and the same role has been attributed to the carboxyl-terminal valine signal (35) . However, the two-hybrid screen applied to the cytosolic tail of proTGFα led to the identification of a specific interacting protein, named 'TACIP18' (43) . This is a PDZ protein that, at variance with other members of the family that interact with the cytosolic tail of transmembrane receptors at the plasma membrane, is apparently located in the initial compartments of the secretory pathway (43) (44) (45) .
TACIP18 interacts only with immature forms of proTGFα containing the terminal valine;
thus it could represent a cell-surface targeting factor specific for proTGFα (43, 44) .
Functional evidence is required to confirm this hypothesis, but similar cases have been by guest on http://www.jbc.org/ Downloaded from 15 described (46) . Yeast permeases require a functional Shr3p protein to reach the cell surface, otherwise they are stored in the ER, which results in defective amino acid uptake (47, 48) .
Work is in progress in our laboratory to verify if TACIP18 interacts also with CD8α glycoprotein and to search for other partner proteins that assist export of CD8α from the ER Finally, the mutational analysis data indicate that the arginine and tyrosine residues at position -2 and -1, respectively, play a minor role in ER export. However, a detailed analysis is required to define precisely the sequence of a signal and the role of the surrounding amino acids. For instance, in the case of the diacidic signal, either an adjacent tyrosine-based motif or the flanking residues is important for ER export (11, 12) . We will address these questions using the assays described here and the data on all species in which CD8α has been sequenced. 
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